Toremifene 40mg x 30ml

Description

Toremifene 40mg x 30ml

Toremifene (also known under its brand and trade name of Fareston) is a member of a category, family, and class of drugs that are known as SERMs (Selective Estrogen Receptor Modulators). SERMs fall under an even broader category of drugs that are known as anti-estrogens, and the cousin family of SERMs (that also fall under anti-estrogens) are aromatase inhibitors, commonly abbreviated as AIs. SERMs include compounds such as Toremifene, Nolvadex (Tamoxifen), and Clomid (Clomiphene Citrate). Aromatase inhibitors (AIs) include compounds such as Arimidex (Anastrozole), Aromasin (Exemestane), and Letrozole (Femara). Although the two fall under the category of anti-estrogens, they are both sub-categories that branch off into their own families, as SERMs and AIs differ greatly in their mechanism of action within the human body concerning how they control or block Estrogen. There has been much misunderstanding and misconception in previous decades as to what each of these do, and this should always be first clarified to the reader before describing Toremifene. As far as Toremifene is concerned, it is a SERM with mixed agonist and antagonist properties on the Estrogen receptor, and is classified as a triphenylethylene analogue that is very similar in structure to Nolvadex (Tamoxifen) and Clomid (Clomiphene Citrate). Toremifene (Fareston) could be considered a very close sister to Nolvadex, as they are very similar.

Toremifene is also a non-steroidal compound. It is classified as a breast cancer drug in the treatment of female post-menopausal breast cancer that is determined to be Estrogen-receptor positive (or Estrogen-receptor unknown). What this means is that it is a drug that is utilized for the purpose of blocking and treating female breast cancer that is exacerbated by Estrogen via Estrogen’s activity at breast tissue receptors, which can promote cancerous growth through its tissue growth promoting activity within breast tissue. Toremifene, as previously described, binds to these receptor sites and blocks the ability for Estrogen itself to continue activating receptor sites within breast tissue, thus blocking or halting the progress of tumor growth that could be exacerbated by Estrogen.

Molecular Formula:  C32H36ClNO8

Molar Mass:             405.959 g/mol

THIS PRODUCT IS INTENDED FOR RESEARCH ONLY. This designation allows the use of research peptides strictly for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product is NOT for human use and can be harmful if ingested. This product is for research/laboratory use only. This product is NOT in a sterile solution and is NOT to be injected. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and should not be misbranded, misused or mislabeled as a drug, food or cosmetic.